Patients taking basal insulin ( with or without oral agents ) with HbA@c @-@ @ % ( @-@ mmol/mol ) entered a glargine standardization period , followed by randomization to albiglutide , @ mg weekly ( n = @ ) , subsequently uptitrated to @ mg , if necessary , or thrice-daily prandial lispro ( n = @ ) while continuing metformin and/or pioglitazone .